Back to Home|Learning Hub

27th Annual International Lung Cancer Congress® - Learning Hub

Stay up to date with the latest advances in lung cancer through the 27th Annual International Lung Cancer Congress® Learning Hub.

Designed for easy, on-demand access, the hub features expert-led presentations, slides, and videos covering emerging agents and approaches in lung cancer, including immunotherapy, targeted therapy, antibody-drug conjugates, bispecific agents, and monitoring for minimal residual disease. Whether you attended the meeting or are catching up, this free resource offers a convenient way to revisit insights and apply the latest developments to your clinical practice—all in 1 place.

This activity is supported by educational grants from AbbVie, Inc; AstraZeneca Pharmaceuticals; Exact Sciences Corporation; Merck & Co, Inc; Nuvalent, Inc; Partner Therapeutics, Inc; and Revolution Medicines, Inc.

9 Modules
Sep 30, 2026 – Oct 1, 2027

Browse and take individual modules below, or enroll in the full path to track your overall progress.

27th Annual International Lung Cancer Congress® - Learning Hub

Main Conference